18F-FDG PET/CT Predicts Response to HER2-directed Neoadjuvant Therapy

被引：1
|
作者：
Diwanji, Devan
Ray, Kimberly
Hylton, Nola
机构：
来源：
RADIOLOGY-IMAGING CANCER | 2021年 / 3卷 / 05期
关键词：
D O I：
10.1148/rycan.2021219021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：1
相关论文
共 50 条
  • [1] 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
    Krause, Bernd J.
    Herrmann, Ken
    Wieder, Hinrich
    zum Bueschenfelde, Christian Meyer
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 89S - 96S
  • [2] The utility of 18F-FDG PET/CT for monitoring of neoadjuvant therapy response in breast cancer
    Xing, W.
    Li, Q.
    Jiang, C.
    Chen, B.
    Sun, Y.
    BREAST, 2019, 44 : S76 - S77
  • [3] Tumor metabolism with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer
    Garcia Vicente, Ana Maria
    Soriano, Angel
    Leon Martin, Alberto
    Cruz Mora, Miguel Angel
    Munoz Sanchez, Maria del Mar
    Relea Calatayud, Fernanda
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [4] Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer
    Garcia Vicente, Ana Maria
    Cruz Mora, Miguel Angel
    Leon Martin, Antonio Alberto
    Munoz Sanchez, Maria del Mar
    Relea Calatayud, Fernanda
    Van Gomez Lopez, Ober
    Espinosa Aunion, Ruth
    Gonzalez Ageitos, Ana
    Soriano Castrejon, Angel
    TUMOR BIOLOGY, 2014, 35 (11) : 11613 - 11620
  • [5] Neurolymphomatosis on 18F-FDG PET/CT Diagnosis and Therapy Response
    Gykiere, Pieterjan
    Jans, Lennart
    Degrieck, Bert
    Goethals, Ingeborg
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) : 142 - 143
  • [6] 18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer
    Ebinc, Senar
    Guzel, Yunus
    Oruc, Zeynep
    Komek, Halil
    Kalkan, Ziya
    Can, Canan
    Tasdemir, Bekir
    Urakci, Zuhat
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Isikdogan, Abdurrahman
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (01) : 81 - 90
  • [7] Utility of 18F-FDG PET and CT to assess response to neoadjuvant chemotherapy.
    Chaft, Jamie E.
    Naidoo, Jarushka
    Dunphy, Mark
    Woo, Kaitlin
    Sima, Camelia S.
    Downey, Robert J.
    Travis, William D.
    Kris, Mark G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] 18F-FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma
    Wang, Shuohua
    Di, Shouyin
    Lu, Jing
    Xie, Shun
    Yu, Zhenyang
    Liang, Yingkui
    Gong, Taiqian
    THORACIC CANCER, 2023, 14 (24) : 2338 - 2349
  • [9] 18F-FDG PET/CT could predict pathologic response to the neoadjuvant therapy in resectable intrahepatic cholangiocarcinoma
    Tan, Hui
    Shi, Hongcheng
    Wu, Jianmao
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [10] The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer
    Murcia Durendez, M. J.
    Frutos Esteban, L.
    Lujan, J.
    Frutos, M. D.
    Valero, G.
    Navarro Fernandez, J. L.
    Salem, L. Mohamed
    Ruiz Merino, G.
    Claver Valderas, M. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 91 - 97
12345